Shah Jatin
SEC CIK 1782186 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | EVP, Chief Medical Off | 129.4K | — | $32.6K | 3 | 2021-07-12 | 2022-02-17 |
Most active insiders at KPTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Paulson Richard A. | Pres, CEO, Dir | — | $137.2K |
| 2 | Poulton Stuart | EVP, Chief Development Off | — | $56.4K |
| 3 | Rangwala Reshma | EVP, Chief Medical Off | — | $55.6K |
| 4 | Cheng Sohanya Roshan | EVP, Chief Commercial Off | — | $46.4K |
| 5 | Mano Michael | SVP, GC, Sec | — | $35.7K |
| 6 | Macomber Lori | EVP, CFO, Treas | — | $10.2K |
| 7 | Abate Kristin | CAO | — | $10.0K |
| 8 | Su Zhen | Dir | — | — |
| 9 | Oliger Christy J. | Dir | — | — |
| 10 | Schor Chen | Dir | — | — |
Shah Jatin made no open-market trades at KPTI in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-22 | 2022-02-17 | KPTI | Karyopharm Therapeutics Inc. | Shah Jatin | EVP, Chief Medical Off | S - Sale | $12.12 | -1,306 | 129.4K | -1.0% | -$15.8K | |
| 2022-02-09 | 2022-02-07 | KPTI | Karyopharm Therapeutics Inc. | Shah Jatin | EVP, Chief Medical Off | S - Sale | $9.86 | -1,704 | 130.8K | -1% | -$16.8K | |
| 2021-07-13 | 2021-07-12 | KPTI | Karyopharm Therapeutics Inc. | Shah Jatin | EVP, Chief Medical Off | F - Tax | $9.73 | -665 | 131.1K | -0.5% | -$6,470 |
Purchase Sale Sale after option exercise All abbreviations